Home › Ovarian Cancer › Pennsylvania › York
Ovarian Cancer clinical trials in York, PA
6 studies for Ovarian Cancer are looking for participants at sites in and around York (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RecruitingPhase 1/2
- WellSpan York Cancer Center, York
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
RecruitingPhase 3
- Wellspan Gynecologic Oncology, York
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RecruitingObservational study
- WellSpan Medical Oncology & Hematology at York Cancer Center, York
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RecruitingPhase 3
- WellSpan Health-York Cancer Center, York
- WellSpan Health-York Hospital, York
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
RecruitingPhase 3
- WellSpan Health, York
WellSpan-THRIVE Cancer QOL Study
RecruitingObservational study
- WellSpan York Cancer Center, York
About Ovarian Cancer
Ovarian cancer is a cancerous tumor that forms in the tissues of an ovary. The ovaries are a pair of female reproductive glands that make eggs and female hormones.
More about Ovarian Cancer on MedlinePlus
Ovarian Cancer trials in other cities
- Houston, TX89 studies
- New York City, NY69 studies
- Boston, MA61 studies
- Los Angeles, CA50 studies
- Nashville, TN49 studies
- Arlington, VA46 studies
- Philadelphia, PA44 studies
- Columbus, OH39 studies
- St. Louis, MO38 studies
- Chicago, IL36 studies
- San Antonio, TX31 studies
- Cleveland, OH30 studies
Other studies in York
- Non-Small Cell Lung Cancer15 studies
- Cancer (all types)8 studies
- Breast Cancer8 studies
- Lung Cancer8 studies
- Head and Neck Squamous Cell Carcinoma7 studies
- Prostate Cancer5 studies
- Coronary Artery Disease5 studies
- Esophageal Cancer4 studies
- Triple-Negative Breast Cancer4 studies
- Colorectal Cancer4 studies
- Endometrial Cancer4 studies
- Colon Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.